Critical

Malignant hyperthermia

Anaesthetic hypermetabolic crisis · Shock / Sepsis
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Life-threatening hypermetabolic reaction to volatile anaesthetics or suxamethonium in susceptible patients, with rising CO2, rigidity, hyperthermia and acidosis.

Red flags

  • Unexplained rising end-tidal CO2
  • Masseter/generalised rigidity
  • Rapidly rising temperature
  • Hyperkalaemia and arrhythmia

Assessment

Differential diagnosis

  • Thyroid storm
  • Neuroleptic malignant/serotonin syndrome
  • Sepsis
  • Inadequate ventilation
  • Phaeochromocytoma

Investigations

  • Rising end-tidal CO2 (early sign)
  • VBG (mixed acidosis), potassium
  • Creatine kinase and myoglobin
  • Core temperature

Management

  • Stop all volatile agents and suxamethonium immediately
  • Call for help and switch to a clean circuit; hyperventilate with 100% oxygen
  • Give dantrolene without delay and repeat as needed
  • Actively cool the patient
  • Treat hyperkalaemia, acidosis and arrhythmia
  • ICU care; monitor for rhabdomyolysis and recrudescence

Drugs & doses

Dantrolene (muscle relaxant) - IV 2.5 mg/kg, repeat to effect
Calcium/insulin-dextrose for hyperkalaemia
Active cooling and supportive measures

Disposition

ICU; refer for MH susceptibility testing.

Complications & pitfalls

  • Hyperkalaemic arrest
  • Rhabdomyolysis and AKI
  • DIC
  • Recrudescence

Exam pearls

  • Rising end-tidal CO2 is often the earliest sign
  • Dantrolene must be given early and repeatedly
  • Refer for later susceptibility testing and family screening

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.